Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Mabs|January 11, 2023
HDX-MS study on garadacimab binding to activated FXII reveals potential binding interfaces through differential solvent exposureSaw Yen Ow, Eugene A Kapp, Vesna Tomasetig, et al.
Cells|July 13, 2026
Engineered Trivalent Human IgG1-Fc Proteins for Potent Complement InhibitionIan K Campbell, Daniel Ortiz, Carlos Bosques, et al.
Blood Advances|May 7, 2020
FVIII half-life extension by coadministration of a D'D3 albumin fusion protein in mice, rabbits, rats, and monkeysSabine Pestel, Hans-Wilhelm Beltz, Philipp Claar, et al.
Journal of Thrombosis and Haemostasis : JTH|August 1, 2021
Increased potency of recombinant VWF D'D3 albumin fusion proteins engineered for enhanced affinity for coagulation factor VIIIJenny Chia, Sabine Pestel, Isabelle Glauser, et al.
The Biochemical Journal|April 26, 2022
Sialylation-dependent pharmacokinetics and differential complement pathway inhibition are hallmarks of CR1 activity in vivoSandra Wymann, Marcel Mischnik, David Leong, et al.
Pageof 1